Skip to main content
. 2019 Jun 25;39(6):BSR20190019. doi: 10.1042/BSR20190019

Table 3. Signaling pathway enrichment analysis of differentially expressed genes in PABC.

DEGs Biological pathway Count P-value Mapped gene names
Up-regulated Fatty acid activation 2 0.00 ACSBG1, SL6
FGF signaling pathway 3 0.00 STAT5B, CG1, MP9
LPA receptor mediated events 4 0.00 PLCG1, XN, DCY7, MP9
Cell-extracellular matrix interactions 2 0.00 PARVB, XN
CXCR4-mediated signaling events 5 0.00 STAT5B, LCG1, XN, TPN7, MP9
EGFR interacts with phospholipase C-gamma 2 0.01 PLCG1, DCY7
Signaling by EGFR 3 0.02 PLCG1, XN, DCY7
Chemokine receptors bind chemokines 2 0.02 CXCR5, XCL13
E-cadherin signaling in the nascent adherens junction 5 0.02 STAT5B, LCG1, DCY7, TGB7, MMP9
IL6-mediated signaling events 2 0.03 IRF1, TNFSF11
Down-regulated Activation of DNA fragmentation factor 2 0.00 HMGB1, KPNA1
Apoptosis induced DNA fragmentation 2 0.00 HMGB1, KPNA1
Valine degradation I 2 0.00 ACADSB, HIBADH
Apoptotic execution phase 3 0.00 HMGB1, KPNA1, DNM1L
Notch signaling pathway 4 0.00 AR, NCOR1, RAB11A, MIB1
Branched-chain amino acid catabolism 2 0.00 ACADSB, HIBADH
PIP3 activates AKT signaling 2 0.01 AKT1S1, CREB1
Glutamate biosynthesis II 1 0.01 GLUD1
PI-3K cascade 2 0.02 AKT1S1, CREB1
AKT-mediated inactivation of FOXO1A 1 0.02 CREB1

Count: the number of enriched genes in each term.